Disorders of bone density and structure Musculoskeletal Diseases Disorders of bone density and structure
Conditions
Interventions
Participants in Phase 1 will be asked to consent to the processing of their radiographs (X-ray photos) using the Trueview® technology. In cases where their standard set of radiographs requires an ASG
Sponsors
Ibex Innovations (United Kingdom)
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Patients who meet the following criteria will be considered eligible for Phase 1 of study: 1. Caucasian male or female, at least 50 years of age attending for a DEXA scan of Neck of Femur (for measurement of bone mineral density) 2. Patient able to comprehend and sign the informed consent prior to enrolment in the study Patients who meet the following criteria will be considered eligible for Phase 2 of study: 1. Male or female, 18 years of age or over, attending orthopaedic outpatient’s clinic and requiring plain radiographs of wrist or shoulder or pelvis 2. Patient able to comprehend and sign the informed consent prior to enrolment in the study
Exclusion criteria
Exclusion criteria: Phase 1: 1. Women who are pregnant or are breastfeeding 2. Concurrent participation in another experimental intervention or drug study 3. Has an implant or other radio-opaque foreign body in the location of the assessment 4. Unwilling or unable to provide informed consent Phase 2: 1. Women who are pregnant or are breastfeeding 2. Concurrent participation in another experimental intervention or drug study 3. Unwilling or unable to provide informed consent 4. Currently wearing a cast on assessment site that is not intended to be removed prior to radiographic assessment 5. Has an implant or other radio-opaque foreign body in the location of the assessment
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Bone mineral density (BMD) as determined from the Trueview 1.0 software and DEXA system | — |
Countries
England, United Kingdom
Contacts
Public ContactRoel Derkman
Outcome results
None listed